Inspire Medical Systems, Inc. (INSP) — Fair Value Analysis

Base-case fair value (P50): $47.04 · Current price: $41.41 · Verdict: Fairly Valued

The Verdict on INSP

INSPIRE MEDICAL SYSTEMS INC (INSP) is currently assessed as Fairly Valued based on our Monte Carlo simulations. With a $41.41 and a median fair value (P50) of $47.04, our models indicate a potential +13.6% upside to the current trading level. This assessment reflects the probabilistic outcomes generated by thousands of forward-looking scenarios for INSP, suggesting that its market price largely aligns with its intrinsic value distribution, with a slight tilt towards potential appreciation.

How INSP stacks up against peers

INSP's operational and financial health is rated as average compared to its sector peers. This average quality tier is a key input into our valuation models, influencing the parameters and assumptions within the Monte Carlo simulations. While an average rating suggests no immediate red flags, it also implies that INSP's current valuation, trading at $41.41 against a $47.04 median fair value, incorporates a balanced view of its fundamental strengths and weaknesses relative to its competitive landscape. The implied +13.6% reflects this balanced perspective, rather than significant undervaluation driven by exceptional quality.

What this means for investors

For investors considering INSP, the Fairly Valued verdict from our Monte Carlo simulations suggests a current market price of $41.41 that closely tracks its intrinsic value. The $47.04 median fair value points to a modest +13.6% potential, reflecting a scenario where the stock performs in line with its probabilistic future outcomes rather than offering deep value or being significantly overextended. While a downside scenario is always possible, the current data does not suggest an outsized risk, nor a robust bull case without further fundamental catalysts. FairCurve's Monte Carlo analysis provides a dynamic assessment, moving beyond single-point estimates to reflect the full spectrum of potential future outcomes. To see the full bear/bull distribution and track INSP's fair value as new fundamentals are released, sign up for a free FairCurve account today.